标题
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
作者
关键词
-
出版物
Neurotherapeutics
Volume 20, Issue 4, Pages 914-931
出版商
Springer Science and Business Media LLC
发表日期
2023-07-25
DOI
10.1007/s13311-023-01405-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro‐meso‐macro perspective
- (2023) María P. Aranda et al. Alzheimer's and Dementia: Translational Research and Clinical Interventions
- The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
- (2022) Kirsten L. Viola et al. Frontiers in Neuroscience
- The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
- (2022) Marianne Chapleau et al. JOURNAL OF NUCLEAR MEDICINE
- Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
- (2022) Semira Abdi Beshir et al. International Journal of Alzheimer's Disease
- Advancing innovative clinical trials to efficiently deliver medicines to patients
- (2022) Robert A. Beckman et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease
- (2022) Susanne Ostrowitzki et al. JAMA Neurology
- A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial
- (2022) Eric M. Reiman et al. Alzheimers & Dementia
- PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
- (2022) Jing Wang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Lecanemab in Early Alzheimer’s Disease
- (2022) Christopher H. van Dyck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
- (2022) Randall J. Bateman et al. Alzheimers Research & Therapy
- ENGAGE and EMERGE: Truth and consequences?
- (2021) Lewis H. Kuller et al. Alzheimers & Dementia
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer’s disease pathology in aged squirrel monkeys
- (2021) Akash G Patel et al. BRAIN
- Family members' perspectives on learning cognitively unimpaired older adults' amyloid‐β PET scan results
- (2021) Emily A. Largent et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria
- (2021) Sanne Franzen et al. Alzheimers & Dementia
- TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment
- (2021) Sergey Shcherbinin et al. Alzheimers & Dementia
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
- (2021) Stephen Salloway et al. JAMA Neurology
- Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
- (2020) Emily A. Largent et al. PLoS One
- Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
- (2020) Irina Petrushina et al. NEUROBIOLOGY OF DISEASE
- Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
- (2020) Joshua D. Grill et al. JAMA Neurology
- ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
- (2019) Anja Soldan et al. NEUROLOGY
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A brief history of “Alzheimer disease”
- (2019) David S. Knopman et al. NEUROLOGY
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults
- (2019) Jennifer S. Rabin et al. JAMA Neurology
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
- (2018) Sofia Söllvander et al. Journal of Neuroinflammation
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
- (2018) Joseph W. Arndt et al. Scientific Reports
- Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
- (2018) Ana-María Lacosta et al. Alzheimers Research & Therapy
- SPECT and PET imaging in Alzheimer’s disease
- (2018) Varvara Valotassiou et al. ANNALS OF NUCLEAR MEDICINE
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
- (2018) Kristina Magnusson et al. JOURNAL OF ALZHEIMERS DISEASE
- The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
- (2018) Stina Tucker et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
- (2018) Francesco Panza et al. Expert Review of Neurotherapeutics
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials
- (2017) Donna M. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint
- (2016) Nikita Rudinskiy et al. Alzheimers & Dementia
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- A critical concentration of N-terminal pyroglutamylated amyloid beta drives the misfolding of Ab1-42 into more toxic aggregates
- (2016) Denise Galante et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils
- (2016) Michael T. Colvin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
- (2015) A. D. Joshi et al. JOURNAL OF NUCLEAR MEDICINE
- A Hexameric Peptide Barrel as Building Block of Amyloid-β Protofibrils
- (2014) Christofer Lendel et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Role of the Fast Kinetics of Pyroglutamate-Modified Amyloid-β Oligomers in Membrane Binding and Membrane Permeability
- (2014) Joon Lee et al. BIOCHEMISTRY
- Small Aβ1-42oligomer-induced membrane depolarization of neuronal and microglial cells: Role of N-methyl-D-aspartate receptors
- (2014) Ramune Morkuniene et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease
- (2011) Sadim Jawhar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo
- (2011) Tomohiro Umeda et al. JOURNAL OF NEUROSCIENCE RESEARCH
- BDNF-, IGF-1- and GDNF-Secreting Human Neural Progenitor Cells Rescue Amyloid β-Induced Toxicity in Cultured Rat Septal Neurons
- (2011) Narisorn Kitiyanant et al. NEUROCHEMICAL RESEARCH
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
- (2010) Cynthia A. Massaad et al. ANTIOXIDANTS & REDOX SIGNALING
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- Stabilization of neurotoxic Alzheimer amyloid- oligomers by protein engineering
- (2010) A. Sandberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
- (2009) Wei-Qin Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta
- (2009) G. Pigino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease
- (2008) Hans Basun et al. ARCHIVES OF NEUROLOGY
- A Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
- (2008) N. H. Varvel et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
- (2007) Fernanda G. De Felice et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now